Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT04643769
What this trial is testing

Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Orinove, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT03215927
What this trial is testing

Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease

Who this might be right for
MyositisInterstitial Lung Disease
Rohit Aggarwal, MD 20
Not applicableStudy completedNCT00001618
What this trial is testing

Segmental Bronchoalveolar Lavage

Who this might be right for
AsthmaPulmonary Fibrosis
National Heart, Lung, and Blood Institute (NHLBI) 153
Post-approval studies (Phase 4)Study completedNCT03503188
What this trial is testing

Digital Auscultation Test - IPF Data Collection

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 274
Early research (Phase 1)Looking for participantsNCT03535545
What this trial is testing

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Pulmonary FibrosisLung Cancer
Massachusetts General Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Not applicableUnknownNCT04561479
What this trial is testing

Pulmonary Rehabilitation in Patients With Chronic Fibrotic Hypersensitivity Pneumonitis

Who this might be right for
Hypersensitivity PneumonitisExtrinsic Allergic Alveolitis
Gazi University 30
Not applicableLooking for participantsNCT07269262
What this trial is testing

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Who this might be right for
Progressive Pulmonary FibrosisInterstitial Lung Disease
Medical University of South Carolina 170
Early research (Phase 1)Ended earlyNCT02013700
What this trial is testing

Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Joshua M Hare 9
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Not applicableUnknownNCT04320667
What this trial is testing

Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis

Who this might be right for
Glomerulonephritis Acute
Charite University, Berlin, Germany 79
Early research (Phase 1)Study completedNCT06230822
What this trial is testing

Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Wuhan Optics Valley Vcanbiopharma Co., Ltd. 9
Not applicableUnknownNCT02960672
What this trial is testing

Sequential Changes of Serum KL-6 Predict Progression in Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease, Desquamative
The First Affiliated Hospital of Guangzhou Medical University 70
Large-scale testing (Phase 3)UnknownNCT02417883
What this trial is testing

Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Instituto Nacional de Cardiologia Ignacio Chavez 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05828953
What this trial is testing

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Who this might be right for
Interstitial Lung Diseases
First Affiliated Hospital of Wenzhou Medical University 30
Not applicableNot Yet RecruitingNCT07810153
What this trial is testing

Diaphragmatic Release vs Inspiratory Muscle Training in Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Pharos University in Alexandria 40
Not applicableStudy completedNCT00014859
What this trial is testing

Epidemiology of Surfactant Protein-B Deficiency

Who this might be right for
Lung DiseasesRespiratory Distress Syndrome, NewbornPulmonary Surfactant+1 more
Washington University School of Medicine 5,176
Not applicableStudy completedNCT07031362
What this trial is testing

The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
IPFPulmonary Fibrosis
Izmir Katip Celebi University 50
Not applicableStudy completedNCT02456246
What this trial is testing

Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRT

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
University Health Network, Toronto 45
Not applicableStudy completedNCT04022902
What this trial is testing

The Experience of Patients and Family Caregivers in Managing Pneumoconiosis in the Family Context

Who this might be right for
Pneumoconiosis
Chinese University of Hong Kong 83
Next Page